Third party reports are also surfacing claiming that the company's former esoteric darling, GenPap, was in fact a test that was simply bought and used under license from a Korean company, Seegene.
MIAMI--(BUSINESS WIRE)--OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback